Wuillemin WA - Search Results

1

Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.

Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I, Kremer-Hovinga J, Binder BR, Lämmle B. Merlo C, et al. Among authors: wuillemin wa. Atherosclerosis. 2002 Apr;161(2):261-7. doi: 10.1016/s0021-9150(01)00666-9. Atherosclerosis. 2002. PMID: 11888508

2

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

Redondo M, Watzke HH, Stucki B, Sulzer I, Biasiutti FD, Binder BR, Furlan M, Lämmle B, Wuillemin WA. Redondo M, et al. Among authors: wuillemin wa. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1020-5. doi: 10.1161/01.atv.19.4.1020. Arterioscler Thromb Vasc Biol. 1999. PMID: 10195931

3

Increased fibrin monomer plasma concentration in stable coronary artery disease in patients without oral anticoagulation.

Redondo M, Caliezi C, Biasiutti FD, Lämmle B, Wuillemin WA. Redondo M, et al. Among authors: wuillemin wa. Atherosclerosis. 2001 Aug;157(2):417-22. doi: 10.1016/s0021-9150(00)00731-0. Atherosclerosis. 2001. PMID: 11472742

4

Hemostatic risk factors in ischemic stroke.

Demarmels Biasiutti F, Berger D, Mattle HP, Lämmle B, Wuillemin WA. Demarmels Biasiutti F, et al. Among authors: wuillemin wa. Thromb Haemost. 2003 Dec;90(6):1094-9. doi: 10.1160/TH03-03-0134. Thromb Haemost. 2003. PMID: 14652642

5

Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence.

Barco S, Sollfrank S, Trinchero A, Adenaeuer A, Abolghasemi H, Conti L, Häuser F, Kremer Hovinga JA, Lackner KJ, Loewecke F, Miloni E, Vazifeh Shiran N, Tomao L, Wuillemin WA, Zieger B, Lämmle B, Rossmann H. Barco S, et al. Among authors: wuillemin wa. J Thromb Haemost. 2020 Jul;18(7):1598-1617. doi: 10.1111/jth.14805. Epub 2020 May 15. J Thromb Haemost. 2020. PMID: 32202057 Free article.

6

Factor XII clotting activity and antigen levels in patients with thromboembolic disease.

von Känel R, Wuillemin WA, Furlan M, Lämmle B. von Känel R, et al. Among authors: wuillemin wa. Blood Coagul Fibrinolysis. 1992 Oct;3(5):555-61. doi: 10.1097/00001721-199210000-00006. Blood Coagul Fibrinolysis. 1992. PMID: 1450322

7

Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma.

Wuillemin WA, Furlan M, Stricker H, Lämmle B. Wuillemin WA, et al. Thromb Haemost. 1992 Feb 3;67(2):219-25. Thromb Haemost. 1992. PMID: 1621242

8

Functional characterization of an abnormal factor XII molecule (F XII Bern).

Wuillemin WA, Huber I, Furlan M, Lämmle B. Wuillemin WA, et al. Blood. 1991 Aug 15;78(4):997-1004. Blood. 1991. PMID: 1868256 Free article.

9

Purified factor XII has a higher specific activity than the parent molecule in plasma.

Wuillemin WA, Furlan M, Huber I, Lämmle B. Wuillemin WA, et al. Thromb Haemost. 1991 Feb 12;65(2):169-73. Thromb Haemost. 1991. PMID: 2053104

10

A quantitative dot immunobinding assay for coagulation factor XII in plasma.

Wuillemin WA, Furlan M, Lämmle B. Wuillemin WA, et al. J Immunol Methods. 1990 Jun 12;130(1):133-40. doi: 10.1016/0022-1759(90)90307-h. J Immunol Methods. 1990. PMID: 2358685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

177 results

Search Page